RCTs. It should be mentioned that PS was not found in 25% of patients. Therefore, real-world data are a valuable addition to trial results because they deepen the understanding of the outcome of therapies in patients encountered on a day-to-day basis
Search Results
Esther N. Pijnappel, Willemieke P.M. Dijksterhuis, Lydia G. van der Geest, Judith de Vos-Geelen, Jan Willem B. de Groot, Marjolein Y.V. Homs, Geert-jan Creemers, Nadia Haj Mohammad, Marc G. Besselink, Hanneke W.M. van Laarhoven, Johanna W. Wilmink, and for the Dutch Pancreatic Cancer Group
Bishal Gyawali
or none a decade ago, but the billion dollar question is whether outcomes for patients with advanced liver cancer have improved as a result. Some of the statistics are concerning. Although it is too early to observe the effect of new drug approvals
Mohammad Abu Zaid, Wambui G. Gathirua-Mwangi, Chunkit Fung, Patrick O. Monahan, Omar El-Charif, Annalynn M. Williams, Darren R. Feldman, Robert J. Hamilton, David J. Vaughn, Clair J. Beard, Ryan Cook, Sandra K. Althouse, Shirin Ardeshir-Rouhani-Fard, Paul C. Dinh Jr, Howard D. Sesso, Lawrence H. Einhorn, Sophie D. Fossa, Lois B. Travis, and for the Platinum Study Group
: TCS completed a questionnaire regarding health outcomes, lifestyle behaviors, and current prescription medications (including antihypertensive, diabetic, and lipid-lowering medications). Demographic information included age at cancer diagnosis and
Maxwell T. Vergo and Amelia M. Cullinan
process, and therefore involvement at least 3 to 6 months before cessation of chemotherapy would be ideal to affect outcomes. Figure 1. Palliative care integrated into the continuum of care. Applying these criteria to the present case, Mr
Jad Chahoud, Adele Semaan, and Alyssa Rieber
Background The health care system in the United States is characterized by an unsustainable increase in spending with penultimate outcomes. 1 , 2 In 2013, the United States spent a total of $2.9 trillion on health, which is approximately $9
Joyce Valerie Veld, Femke Julie Amelung, Wernard Aat Antoine Borstlap, Emo Eise van Halsema, Esther Catharina Josephina Consten, Peter Derk Siersema, Frank ter Borg, Edwin Silvester van der Zaag, Paul Fockens, Willem Adrianus Bemelman, Jeanin Elise van Hooft, Pieter Job Tanis, and for the Dutch Snapshot Research Group
-term outcomes with additional procedural and long-term surgical and oncologic data through chart review using a web-based tool meeting Dutch privacy regulations by Medical Research Data Management. All 77 Dutch hospitals that register patients in the DCRA were
Carme Font, Alberto Carmona-Bayonas, Aranzazu Fernández-Martinez, Carmen Beato, Andrés Vargas, Pere Gascon, and Remedios Otero
spectrum of PE may vary from sudden life-threatening events to unsuspected radiologic findings on scheduled CT scans. 2 , 3 In several series of patients with acute symptomatic PE, cancer has been identified as a predictor for adverse outcomes. 4 , 5
Li-Ting Liu, Qiu-Yan Chen, Lin-Quan Tang, Shan-Shan Guo, Ling Guo, Hao-Yuan Mo, Yang Li, Qing-Nan Tang, Xue-Song Sun, Yu-Jing Liang, Chong Zhao, Xiang Guo, Chao-Nan Qian, Mu-Sheng Zeng, Jin-Xin Bei, Ming-Huang Hong, Jian-Yong Shao, Ying Sun, Jun Ma, and Hai-Qiang Mai
classifications have markedly different survival outcomes. Infection with Epstein-Barr virus (EBV) is strongly linked to NPC. 13 , 14 Previous studies have shown that patients with high levels of pretreatment plasma EBV DNA have higher rates of distant relapse
Areej El-Jawahri, Deborah Forst, Alyssa Fenech, Keri O. Brenner, Amanda L. Jankowski, Lauren Waldman, Isabella Sereno, Ryan Nipp, Joseph A. Greer, Lara Traeger, Vicki Jackson, and Jennifer Temel
their cancer. Figure 1. Patients’ perceptions of their treatment goal and of their oncologist’s goal. Association Between Patients’ Perceptions of Treatment Goals and Patient-Reported Outcomes Figures 2 and 3 depict the rates of clinically significant
Linda Watson, Siwei Qi, Claire Link, Andrea DeIure, Arfan Afzal, and Lisa Barbera
associated severity directly impact the care they require, and patients with multiple and/or severe symptoms may need more support or use additional services. A study conducted in Ontario, Canada, used patient-reported outcomes (PROs) data to examine symptoms
